Metabolism of hCG and hLH to multiple urinary forms

Molecular and Cellular Endocrinology

Volumn 125, Issue 1-2, 1996, Pages 121-131

  Birken, Steven ^a   Kovalevskaya, Galina ^a   O'Connor, John ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Human chorionic gonadotropin; Human luteinizing hormone; Multiple urinary forms

Indexed keywords

CHORIONIC GONADOTROPIN; HORMONE ANTIBODY; LUTEINIZING HORMONE; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT;

CONFERENCE PAPER; FEMALE; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE STRUCTURE; HORMONE URINE LEVEL; HUMAN; HYPOPHYSIS; PLACENTA; POSTMENOPAUSE; PRIORITY JOURNAL; URINALYSIS;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; LUTEINIZING HORMONE; MACROMOLECULAR SUBSTANCES; MENOPAUSE; OVULATION; PITUITARY GLAND; PREGNANCY;

EID: 0030596016     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03942-1     Document Type: Conference Paper

References (83)

1. [1] Catt, K.J. and Dufau, M.L. (1995) Gonadotropic hormones: biosynthesis, secretion, receptors and actions. In: Reproductive Endocrinology (Yen, S.S.C. and Jaffe, R.B., eds.), pp. 105-155, W.B. Saunders, Philadelphia.
2. [2] Baenziger, J.U. (1994) Protein-specific glycosyltransferases: how and why they do it (Review). FASEB J. 8, 1019-1025.
3. [3] Smith, P.L., Bousfield, G.R., Kumar, S., Fiete, D. and Baenziger, J.U. (1993) Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia α 2,3Gal, respectively. J. Biol. Chem. 268, 795-802.
4. [4] Baenziger, J.U., Kumar, S., Brodbeck, R.M., Smith, P.L., and Beranek, M.C. (1992) Circulatory half-life but not interaction with the lutropin/chorionic gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. Proc. Natl. Acad. Sci. USA 89, 334-338.
5. [5] Fiete, D., Srivastava, V., Hindsgaul, O. and Baenziger, J.U. (1991) A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc β 1,4GlcNAc β 1,2Man α that mediates rapid clearance of lutropin (see comments). Cell 67, 1103-1110.
6. [6] Birken, S., Maydelman, Y., Gawinowicz, M.A., Pound, A., Liu, Y. and Hartree, A.S. (1996) Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 137, 1402-1411.
7. [7] Odell, W.D. and Griffin, J. (1989) Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle. J. Clin. Endocrinol. Metab. 69, 528-532.
8. [8] Odell, W.D. and Griffin, J. (1987) Pulsatile secretion of human chorionic gonadotropin in normal adults. New Engl. J. Med. 317, 1688-1691.
9. [9] O'Connor, J.F., Birken, S., Lustbader, J.W., Krichevsky, A., Chen, Y. and Canfield, R.E. (1994) Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements (Review). Endocr. Rev. 15, 650-683.
10. [10] Birken, S., Gawinowicz, M.A., Kardana, A. and Cole, L.A. (1991) The heterogeneity of human chorionic gonadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. Endocrinology 129, 1551-1558.
11. [11] Haavisto, A.-M., Pettersson, K., Bergendahl, M., Virkamäki, A. and Huhtaniemi, I. (1995) Occurrence and biological properties of a common genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab. 80, 1257-1263.
12. [12] Pettersson, K., Ding, Y.Q. and Huhtaniemi, I. (1991) Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin. Clin. Chem. 37(1), 1745-1748.
13. [13] Rajkhowa, M., Talbot, J.A., Jones, P.W., Pettersson, K., Haavisto, A.M., Huhtaniemi, I. and Clayton, R.N. (1995) Prevalence of an immunological LH β-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf) 43, 297-303.
14. [14] Pettersson, K., Ding, Y.Q. and Huhtaniemi, I. (1992) An immunologically anomalous luteinizing hormone variant in a healthy woman. J. Clin. Endocrinol. Metab. 74, 164-171.
15. [15] Okuda, K., Yamada, T., Imoto, H., Komatsubara, H. and Sugimoto, O. (1994) Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions. Biochem. Biophys. Res. Commun. 94, 584-590.
16. [16] Cole, L.A., Seifer, D.B., Kardana, A. and Braunstein, G.D. (1993) Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine. Am. J. Obstet. Gynecol. 93, 1580-1586.
17. [17] Marcillac, I., Troalen, F., Bidart, J.-M., Ghillani, P., Ribrag, V., Escudier, B., Malassagne, B., Droz, J.P., Lhomme, C. and Rougier, P. et al. (1992) Free human chorionic gonadotropin β-subunit in gonadal and nongonadal neoplasms. Cancer Res. 52, 3901-3907.
18. [18] Cole, L.A., Kardana, A., Seifer, D.B. and Bohler Jr., H.C. (1994) Urine hCG β-subunit core fragment, a sensitive test for ectopic pregnancy. J. Clin. Endocrinol. Metab. 94, 497-499.
19. [19] de Medeiros, S.F., Amato, F., Bacich, D., Wang, L., Matthews, C.D. and Norman, R.J. (1992) Distribution of the β-core human chorionic gonadotrophin fragment in human body fluids. J. Endocrinol. 135, 175-188.
20. [20] Kardana, A. and Cole, E.A. (1992) Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free β-subunit. Clin. Chem. 38, 26-33.
21. [21] Cole, L.A., Kardana, A., Andrade-Gordon, P., Gawinowicz, M.A., Morris, J.C., Bergert, E.R., O'Connor, J. and Birken, S. (1991) The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology 129, 1559-1567.
22. [22] Kardana, A., Elliott, M.M., Gawinowicz, M.A., Birken, S. and Cole, L.A. (1991) The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG. Endocrinology 129, 1541-1550.
23. [23] Hoermann, R., Berger, P., Spoettl, G., Gillesberger, F., Kardana, A., Cole, L.A. and Mann, K. (1994) Immunological recognition and clinical significance of nicked human chorionic gonadotropin in testicular cancer. Clin. Chem. 40, 2306-2312.
24. [24] Puisieux, A., Bellet, D., Troalen, F., Razafindratsita, A., Lhomme, C., Bohuon, C. and Bidart, J.-M. (1990) Occurrence of fragmentation of free and combined forms of the β-subunit of human chorionic gonadotropin. Endocrinology 126, 687-694.
25. [25] Iles, R.K., Wathen, N.C., Campbell, D.J. and Chard, T. (1992) Human chorionic gonadotrophin and subunit composition of maternal serum and coelomic and amniotic fluids in the first trimester of pregnancy. J. Endocrinol. 135, 563-569.
26. [26] Yoshimura, M., Nishimura, R., Murotani, A., Miyamoto, Y., Nakagawa, T., Hasegawa, K., Koizumi, T., Shii, K., Baba, S. and Tsubota, N. (1994) Assessment of urinary β-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer. Cancer 73, 2745-2752.
27. [27] de Medeiros, S.F., Amato, F., Matthews, C.D. and Norman, R.J. (1992) Urinary concentrations of β core fragment of hCG throughout pregnancy. Obstet. Gynecol. 80, 223-228.
28. [28] Dharmesh, S.M. and Baenziger, J.U. (1993) Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin. Proc. Natl. Acad. Sci. USA 90, 11127-11131.
29. [29] Yen, S.S.C. (1991) The human menstrual cycle: neuroendocrine regulation. In: Reproductive Endocrinology (Yen, S.S.C. and Jaffe, R.B., eds.), pp. 273-308, W.B. Saunders, Philadelphia.
30. [30] Neven, P., Iles, R.K., Howes, I., Sharma, K., Shepherd, J.H., Edwards, R., Collins, W.P. and Chard, T. (1993) Substantial urinary concentrations of material resembling β-core fragment of chorionic gonadotropin β-subunit in mid-menstrual cycle. Clin. Chem. 39, 1857-1860.
31. [31] Iles, R.K., Lee, C.L., Howes, I., Davies, S., Edwards, R. and Chard, T. (1992) Immunoreactive β-core-like material in normal postmenopausal urine: human chorionic gonadotrophin or LH origin? Evidence for the existence of LH core. J. Endocrinol. 133, 459-466.
32. [32] Birken, S., Chen, Y., Gawinowicz, M.A., Agosto, G.M., Canfield, R.E. and Hartree, A.S. (1993) Structure and significance of human luteinizing hormone-β core fragment purified from human pituitary extracts. Endocrinology 133, 985-989.
33. [33] Kovalevskaya, G., Birken, S., O'Connor, J., Schlatterer, J., Maydelman, Y. and Canfield, R. (1995) HLH β core fragment immunoreactivity in the urine of ovulating women: a sensitive and specific immunometric assay for its detection. Endocrine 3, 881-887.
34. [34] Carter, P.G., Iles, R.K., Neven, P., Ind, T.E., Shepherd, J.H. and Chard, T. (1995) Measurement of urinary β core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance. Br. J. Cancer 71, 350-353.
35. [35] Carter, P.G., Iles, R.K., Neven, P., Ind, T.E., Shepherd, J.H. and Chard, T. (1994) The prognostic significance of urinary β core fragment in premenopausal women with carcinoma of the cervix. Gynecol. Oncol. 55, 271-276.
36. [36] Nishimura, R., Koizumi, T., Morisue, K., Yamanaka, N., Lalwani, R., Yoshimura, M., Nakagawa, T., Shii, K., Hasegawa, K. and Baba, S. (1995) Expression and secretion of the β-subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. Cancer Res. 55, 1479-1484.
37. [37] Kinugasa, M., Nishimura, R., Koizumi, T., Morisue, K., Higashida, T., Natazuka, T., Nakagawa, T., Isobe, T., Baba, S. and Hasegawa, K. (1995) Combination assay of urinary β-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers. Jpn. J. Cancer Res. 86, 783-789.
38. [38] Canfield, R.E. and Ross, G.T. (1976) A new reference preparation of human chorionic ganoadtropin and its subunits. Bull. Who 54, 463-470.
39. [39] Storring, P.L., Gaines-Das, R.E. and Bangham, D.R. (1980) International reference preparation of human chorionic gonadotropin for immunoassay: potency estimates in various bioassay and protein binding assay systems; and international reference preparations of the α- and β-subunits of human chorionic gonadotropin for immunoassay. J. Endocrinol. 84, 295-310.
40. [40] Grotjan, Jr., H.E. and Cole, L.A. (1989) Human chorionic gonadotropin micro-heterogeneity. In: Microheterogeneity of Glycoprotein Hormones (Grotjan, H.R. Jr. and Cole, L.A., eds.), pp. 219-237, CRC Press, Boca Raton, FL.
41. [41] Papandreou, M.J., Asteria, C., Pettersson, K., Ronin, C. and Beck-Peccoz, P. (1993) Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions. J. Clin. Endocrinol. Metab. 76, 1008-1013.
42. [42] Nishimura, R., Kitajima, T., Hasegawa, K., Takeuchi, K. and Mochizuki, M. (1989) Molecular forms of human chorionic gonadotropin in choriocarcinoma serum and urine. Jpn. J. Cancer Res. 80, 968-974.
43. [43] Nishimura, R., Utsunomiya, T., Ide, K., Kitajima, T., Chen, H.C., Strobel, J.L., Hussa, R.O. and Mochizuki, M. (1987) Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies. Jpn. J. Cancer Res. 78, 833-839.
44. [44] Nishimura, R., Mizuochi, T., Utsunomiya, T., Ide, K., Kobata, A. and Mochizuki, M. (1985) Detection of incompletely sialylated human chorionic gonadotropin by peanut agglutinin in choriocarcinoma. Jpn. J. Exp. Med. 55, 75-78.
45. [45] Mizuochi, T., Nishimura, R., Taniguchi, T., Utsunomiya, T., Mochizuki, M., Derappe, C. and Kobata, A. (1985) Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals. Jpn. J. Cancer Res. 76, 752-759.
46. [46] Endo, T., Nishimura, R., Mochizuki, M., Kochibe, N. and Kobata, A. (1988) Altered glycosylation is induced in both α- and β-subunits of human chorionic gonadotropin produced by choriocarcinoma. J. Biochem. (Tokyo) 103, 1035-1038.
47. [47] Amano, J., Nishimura, R., Mochizuki, M. and Kobata, A. (1988) Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. J. Biol. Chem. 263, 1157-1165.
48. [48] Nishimura, R., Shin, J., Ji, I., Middaugh, C.R., Kruggel, W., Lewis, R.V. and Ji, T.H. (1986) A single amino acid substitution in an ectopic α-subunit of a human carcinoma choriogonadotropin. J. Biol. Chem. 261, 10475-10477.
49. [49] Wehmann, R.E., Blithe, D.L., Akar, A.H. and Nisula, B.C. (1990) Disparity between β-core levels in pregnancy urine and serum: implications for the origin of urinary β-core. J. Clin. Endocrinol. Metab. 70, 371-378.
50. [50] Wehmann, R.E., Blithe, D.L., Flack, M.R. and Nisula, B.C. (1989) Metabolic clearance rate and urinary clearance of purified β-core. J. Clin. Endocrinol. Metab. 69, 510-517.
51. [51] Blithe, D.L., Akar, A.H., Wehmann, R.E. and Nisula, B.C. (1988) Purification of β-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-β. Endocrinology 122, 173-180.
52. [52] Krichevsky, A., Armstrong, E.G., Schlatterer, J., Birken, S., O'Connor, J., Bikel, K., Silverberg, S., Lustbader, J.W. and Canfield, R.E. (1988) Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin β-subunit. Endocrinology 123, 584-593.
53. [53] Birken, S., Armstrong, E.G., Kolks, M.A., Cole, L.A., Agosto, G.M., Krichevsky, A., Vaitukaitis, J.E. and Canfield, R.E. (1988) Structure of the human chorionic gonadotropin β-subunit fragment from pregnancy urine. Endocrinology 123, 572-583.
54. [54] Blithe, D.L., Wehmann, R.E. and Nisula, B.C. (1989) Carbohydrate composition of β-core. Endocrinology 125, 2267-2272.
55. [55] de Medeiros, S.F., Amato, F., Matthews, C.D. and Norman, R.J. (1992) Comparison of specific immunoassays for detection of the β-core human chorionic gonadotrophin fragment in body fluids. J. Endocrinol. 135, 161-174.
56. [56] Chatzaki, E., Gallagher, C.J., Iles, R.K., Ind, T.E., Nouri, A.M., Bax, C.M. and Grudzinskas, J.G. (1994) Characterization of the differential expression of marker antigens by normal and malignant endometrial epithelium. Br. J. Cancer 69, 1010-1014.
57. [57] Neven, P., Iles, R.K., Carter, P.G., Shepherd, J.H. and Chard, T. (1994) Diurnal variation of urinary 'hCG β-subunit core fragment' production evaluated in patients with gynecological neoplasms. Clin. Chem. 40, 484-485.
58. [58] Neven, P., Iles, R.K., Lee, C.L., Hudson. C.N., Shepherd, J.H. and Chard, T. (1993) Urinary chorionic gonadotropin subunits and β-core in nonpregnant women. A study of benign and malignant gynecologic disorders. Cancer 71, 4124-4130.
59. [59] Carter, P.G., Iles, R.K., Neven, P., Davies, A.P., Shepherd, J.H. and Chard, T. (1993) The measurement of urinary β core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses. Gynecol. Oncol. 51, 368-371.
60. [60] Lee, C.L., Iles, R.K., Shepherd, J.H., Hudson, C.N. and Chard, T. (1991) The purification and development of a radioimmunoassay for β-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J. Endocrinol. 130, 481-489.
61. [61] Norman, R.J., de Medeiros, S., Amato, F., Davis, G. and Davy, M. (1993) β-core fragment of human chorionic gonadotropin in cervical intraepithelial neoplasia (CIN). Gynecol. Oncol. 49, 16-18.
62. [62] Cuckle, H.S., Iles, R.K., Sehmi, I.K., Chard, T., Oakey, R.E., Davies, S. and Ind, T. (1995) Urinary multiple marker screening for Down's syndrome. Prenatal Diagn. 15, 745-751.
63. [63] Cuckle, H.S., Iles, R.K. and Chard, T. (1994) Urinary β-core human chorionic gonadotrophin: a new approach to Down's syndrome screening. Prenatal Diagn. 14, 953-958.
64. [64] Endo, T., Nishimura, R., Saito, S., Kanazawa, K., Nomura, K., Katsuno, M., Shii, K., Mukhopadhyay, K., Baba, S. and Kobata, A. (1992) Carbohydrate structures of β-core fragments of human chorionic gonadotropin isolated from a pregnant individual. Endocrinology 131, 1457.
65. [65] de Medeiros, S.F., Amato, F., Matthews, C.D. and Norman, R.J. (1993) Molecular heterogeneity of the β-core fragment of human chorionic gonadotrophin. J. Endocrinol. 139, 519-532.
66. [66] Alfthan, H., Haglund, C., Dabek, J. and Stenman, U.H. (1992) Concentrations of human choriogonadotropin, its β-subunit, and the core fragment of the β-subunit in serum and urine of men and nonpregnant women. Clin. Chem. 38, 1981-1987.
67. [67] Alfthan, H., Haglund, C., Roberts, P. and Stenman, U.H. (1992) Elevation of free β-subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 52, 4628-4633.
68. [68] Cole, L.A. and Birken, S. (1988) Origin and occurrence of human chorionic gonadotropin β-subunit core fragment. Mol. Endocrinol. 2, 825-830.
69. [69] Nisula, B.C., Blithe, D.L., Akar, A., Lefort, G. and Wehmann, R.E. (1989) Metabolic fate of human choriogonadotropin (Review). J. Steroid Biochem. Mol. Biol. 33, 733-737.
70. [70] Wehmann, R.E., Amr, S., Rosa, C. and Nisula, B.C. (1984) Metabolism, distribution and excretion of purified human chorionic gonadotropin and its subunits in man. Ann. Endocrinol. 45, 291-295.
71. [71] Wehmann, R.E. and Nisula, B.C. (1981) Metabolic and renal clearance rates of purified human chorionic gonadotropin. J. Clin. Invest. 68, 184-194.
72. [72] Bidart, J.-M., Puisieux, A., Troalen, F., Foglietti, M.-J., Bohuon, C. and Bellet, D. (1988) Characterization of a cleavage product in the human choriogonadotropin β-subunit. Biochem. Biophys. Res. Commun. 154, 626-632.
73. [73] Krichevsky, A., Birken, S., O'Connor, J., Acevedo, H.F., Bikel, K., Lustbader, J., Hartree, A. and Canfield, R.E. (1994) Development, characterization, and application of monoclonal antibodies to the native and synthetic β COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG. Endocrinology 134, 1139-1145.
74. [74] Ward, D.N., Wen, T. and Bousfield, G.R. (1987) Sulfate and phosphate analysis in glycoproteins and other biologic compounds using ion chromatography. Application to glycoprotein hormones and sugar esters. J. Chromatogr. 398, 255-264.
75. [75] Bousfield, G.R. and Ward, D.N. (1992) Reduction and reoxidation of equine gonadotropin α-subunits. Endocrinology 131, 2986-2998.
76. [76] Smith, P.L., Kaetzel, D., Nilson, J. and Baenziger, J.U. (1990) The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity. J. Biol. Chem. 265, 874-881.
77. [77] Hoermann, R., Spoettl, G., Berger, P. and Mann, K. (1995) Immunoreactive human chorionic gonadotropin β core fragment in human pituitary. Exp. Clin. Endocrinol. 103, 324-331.
78. [78] Odell, W.D., Griffin, J., Bashey, H.M. and Snyder, P.J. (1990) Secretion of chorionic gonadotropin by cultured human pituitary cells. J. Clin. Endocrinol. Metab. 71, 1318-1321.
79. [79] Szkdulinski, M.W., Thotakura, R., Tropea, J.E., Grossman, M. and Weintraub, B.D. (1995) Asparagine-linked oligosaccharide structures determine clearance and organ distribution of pituitary and recombinant thyrotropin. Endocrinology 136, 3325-3330.
80. [80] Birken, S., Chen, Y., Gawinowicz, M.A., Lustbader, J.W., Pollak, S., Agosto, G., Buck, R. and O'Connor, J. (1993) Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG β fragment from standard reference preparations and raw urine samples. Endocrinology 133, 1390-1397.
81. [81] Akar, A.H., Gervasi, G., Blacker, C., Wehmann, R.E., Blithe, D.L. and Nisula, B.C. (1990) Human chorionic gonadotrophin-like and β-core-like materials in postmenopausal urine. J. Endocrinol. 125, 477-484.
82. [82] Ehrlich, P.H., Moyle, W.R., Moustafa, Z.A. and Canfield, R.E. (1982) Mixing two monoclonal antibodies yields enhanced affinity for antigen. J. Immunol. 128, 2709-2713.
83. [83] Krichevsky, A., Birken, S., O'Connor, J., Bikel, K., Schlatterer, J., Yi, C., Agosto, G. and Canfield, R. (1991) Development and characterization of a new, highly specific antibody to the human chorionic gonadotropin-β fragment. Endocrinology 128, 1255-1264.